Literature DB >> 28815536

Long Noncoding RNA: Genome Organization and Mechanism of Action.

Vijay Suresh Akhade1, Debosree Pal2, Chandrasekhar Kanduri3.   

Abstract

For the last four decades, we have known that noncoding RNAs maintain critical housekeeping functions such as transcription, RNA processing, and translation. However, in the late 1990s and early 2000s, the advent of high-throughput sequencing technologies and computational tools to analyze these large sequencing datasets facilitated the discovery of thousands of small and long noncoding RNAs (lncRNAs) and their functional role in diverse biological functions. For example, lncRNAs have been shown to regulate dosage compensation, genomic imprinting, pluripotency, cell differentiation and development, immune response, etc. Here we review how lncRNAs bring about such copious functions by employing diverse mechanisms such as translational inhibition, mRNA degradation, RNA decoys, facilitating recruitment of chromatin modifiers, regulation of protein activity, regulating the availability of miRNAs by sponging mechanism, etc. In addition, we provide a detailed account of different mechanisms as well as general principles by which lncRNAs organize functionally different nuclear sub-compartments and their impact on nuclear architecture.

Keywords:  Chromatin; Epigenetics; Gene regulation; Genome organization; Long noncoding RNA

Mesh:

Substances:

Year:  2017        PMID: 28815536     DOI: 10.1007/978-981-10-5203-3_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  99 in total

1.  Identification of long noncoding RNA TC0101441 as a novel biomarker for diagnosis and prognosis of gastric cancer.

Authors:  Weiwei Wang; Jianjun Wu
Journal:  Int J Clin Exp Pathol       Date:  2021-03-01

2.  Conditions of embryo culture from days 5 to 7 of development alter the DNA methylome of the bovine fetus at day 86 of gestation.

Authors:  Yahan Li; Paula Tríbulo; Mohammad Reza Bakhtiarizadeh; Luiz Gustavo Siqueira; Tieming Ji; Rocío Melissa Rivera; Peter James Hansen
Journal:  J Assist Reprod Genet       Date:  2019-12-14       Impact factor: 3.412

Review 3.  Non-coding RNA in alcohol use disorder by affecting synaptic plasticity.

Authors:  Shuang Zhu; Jiaming Wu; Jian Hu
Journal:  Exp Brain Res       Date:  2022-01-13       Impact factor: 1.972

4.  LncRNA SNHG1 alleviates hypoxia-reoxygenation-induced vascular endothelial cell injury as a competing endogenous RNA through the HIF-1α/VEGF signal pathway.

Authors:  Shuangchao Liang; Kai Ren; Buying Li; Fangkuan Li; Zhuowen Liang; Jiqiong Hu; Bei Xu; Andong Zhang
Journal:  Mol Cell Biochem       Date:  2019-12-02       Impact factor: 3.396

5.  Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.

Authors:  Daokun Gui; Hanqi Cao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2020-01-16       Impact factor: 2.416

6.  Delineation of the 1q24.3 microdeletion syndrome provides further evidence for the potential role of non-coding RNAs in regulating the skeletal phenotype.

Authors:  James L Shepherdson; Hongjun Zheng; Ina E Amarillo; Audrey McAlinden; Marwan Shinawi
Journal:  Bone       Date:  2020-10-22       Impact factor: 4.398

Review 7.  The potential role of lncRNAs in osteoporosis.

Authors:  Yinxi He; Yanxia Chen
Journal:  J Bone Miner Metab       Date:  2021-02-10       Impact factor: 2.626

Review 8.  Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer.

Authors:  Xiao-Jing Luo; Qi Zhao; Jia Liu; Jia-Bo Zheng; Miao-Zhen Qiu; Huai-Qiang Ju; Rui-Hua Xu
Journal:  Mol Ther       Date:  2020-12-15       Impact factor: 11.454

Review 9.  Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer.

Authors:  Misako Nagasaka; Mohammed Hafiz Uddin; Mohammed Najeeb Al-Hallak; Sarah Rahman; Suresh Balasubramanian; Ammar Sukari; Asfar S Azmi
Journal:  Mol Cancer       Date:  2021-06-01       Impact factor: 27.401

10.  HOTTIP Enhances Gemcitabine and Cisplatin Resistance Through Sponging miR-637 in Cholangiocarcinoma.

Authors:  Kun Gao; Shuhua Chen; Xiangyu Yang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.